SEC Form 4 reporting owner

Jimenez Freddy A.

Jimenez Freddy A. has filed 2 Form 4 transactions reported between December 4, 2025 and June 25, 2026, as SVP & GENERAL COUNSEL of Celldex Therapeutics, Inc..

Name as filed: Jimenez Freddy A.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$121K
1 lines
Companies
1
with Form 4 filings
Latest transaction
Jun 25, 2026
transaction date

Roles and reported holdings

  • CLDXCelldex Therapeutics, Inc.
    Dec 4, 2025 – Jun 25, 2026

    SVP & GENERAL COUNSEL

    Held directly30,796 sh as of Dec 4, 2025 · Form 4

    24 months: $121K sold

Transaction history

All 2 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 25, 2026CLDXSVP & GENERAL COUNSELGrant or awardCode A · direct93,000—Form 4
Dec 4, 2025CLDXSVP & GENERAL COUNSELOpen-market saleCode S · direct4,166$121K@ $29.09Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.